Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Jazz could pay Aerial BioPharma more than $397M for narcolepsy drug in late-stage testing
Jazz could pay Aerial BioPharma more than $397M for narcolepsy drug in late-stage testing
Jazz could pay Aerial BioPharma more than $397M for narcolepsy drug in late-stage testing
Submitted by
admin
on January 13, 2014 - 10:43am
Source:
Yahoo/AP
News Tags:
Jazz Pharmaceuticals
M&A
Aerial BioPharma
narcolepsy
ADX-N05
Headline:
Jazz could pay Aerial BioPharma more than $397M for narcolepsy drug in late-stage testing
Do Not Allow Advertisers to Use My Personal information
